ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapy.
ITK靶向免疫重塑增强了抗CD19 CAR-T细胞疗法的疗效。
期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-026-03004-2
Li Zhenjun, Lv Liangcheng, Yao Xiaoyu, Feng Zhiwei, Xie Yan, Li Kecheng, Qi Feifei, Yang Mei, Wang Jingwen, Pan Tao, Li Xinghua, Chen Haiyan, Wang Jing, Ding Yanping, Zhu Jun, Song Yuqin, Wang Xiaomin, Ding Ning